SR
Insider
Simon Read
DirectorSimon Read (Director) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Dianthus Therapeutics, Inc. (DNTH). The largest single filing was $327K of DNTH (2,778 sh × $117.55, as filed), executed Aug 19.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
1
0 buys · 1 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$327K
shares × price, as filed
Last traded
Aug 19
Filed Aug 19
Median ADV $122.5M across their filed names
Open performance→Volume by month
Buys $0
Sells $327K
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 12 months
Most traded names
DNTHRecent filings
DNTHSALE
Dianthus Therapeutics, Inc.
View filing →
$327K2,778 sh × $117.55
Exec Aug 19
Filed Aug 19 · 6:02 PM ET